Business Description
Apontis Pharma AG
ISIN : DE000A3CMGM5
Share Class Description:
XTER:APPH: Bearer SharesCompare
Compare
Traded in other countries / regions
APPH.Germany IPO Date
2021-05-11Description
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.45 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -0.47 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.73 | |||||
| Beneish M-Score | -3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2 | |||||
| 3-Year EPS without NRI Growth Rate | -112.3 | |||||
| 3-Year Book Growth Rate | 106 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.56 | |||||
| 9-Day RSI | 68.29 | |||||
| 14-Day RSI | 69.59 | |||||
| 6-1 Month Momentum % | 136.93 | |||||
| 12-1 Month Momentum % | 3.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.21 | |||||
| Quick Ratio | 2.69 | |||||
| Cash Ratio | 2.41 | |||||
| Days Inventory | 119.15 | |||||
| Days Sales Outstanding | 17.04 | |||||
| Days Payable | 135.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.69 | |||||
| Operating Margin % | -40.91 | |||||
| Net Margin % | -30.58 | |||||
| FCF Margin % | -42.9 | |||||
| ROE % | -30.86 | |||||
| ROA % | -19.86 | |||||
| ROIC % | -50.59 | |||||
| ROC (Joel Greenblatt) % | -499.02 | |||||
| ROCE % | -29.67 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.12 | |||||
| PB Ratio | 2.6 | |||||
| Price-to-Tangible-Book | 6.15 | |||||
| EV-to-EBIT | -3.91 | |||||
| EV-to-EBITDA | -4.48 | |||||
| EV-to-Revenue | 1.56 | |||||
| EV-to-FCF | -3.64 | |||||
| Price-to-Net-Current-Asset-Value | 9.32 | |||||
| Earnings Yield (Greenblatt) % | -25.58 | |||||
| FCF Yield % | -20.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apontis Pharma AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 36.964 | ||
| EPS (TTM) (€) | -1.329 | ||
| Beta | 1.69 | ||
| Volatility % | 79.37 | ||
| 14-Day RSI | 69.59 | ||
| 14-Day ATR (€) | 0.288344 | ||
| 20-Day SMA (€) | 8.471 | ||
| 12-1 Month Momentum % | 3.22 | ||
| 52-Week Range (€) | 3.03 - 9.64 | ||
| Shares Outstanding (Mil) | 8.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apontis Pharma AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apontis Pharma AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Apontis Pharma AG Frequently Asked Questions
What is Apontis Pharma AG(XTER:APPH)'s stock price today?
The current price of XTER:APPH is €9.04. The 52 week high of XTER:APPH is €9.64 and 52 week low is €3.03.
When is next earnings date of Apontis Pharma AG(XTER:APPH)?
The next earnings date of Apontis Pharma AG(XTER:APPH) is .
Does Apontis Pharma AG(XTER:APPH) pay dividends? If so, how much?
Apontis Pharma AG(XTER:APPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers